Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses. (2023)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00588-1
PubMed Identifier: 37776877
Publication URI: http://europepmc.org/abstract/MED/37776877
Type: Journal Article/Review
Volume: 23
Parent Publication: The Lancet. Infectious diseases
Issue: 11
ISSN: 1473-3099